OTC Pharmaceuticals in Norway industry profile provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Norway otc pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), and medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2013 annual average exchange rates.
The Norwegian OTC Pharmaceuticals market had total revenues of $364.3m in 2013, representing a compound annual growth rate (CAGR) of 3.8% between 2009 and 2013.
The analgesics segment was the market's most lucrative in 2013, with total revenues of $81.2m, equivalent to 22.3% of the market's overall value.
The performance of the market is forecast to follow a similar pattern with an anticipated CAGR of 3.8% for the five-year period 2013 - 2018, which is expected to drive the market to a value of $438.8m by the end of 2018.
Save time carrying out entry-level research by identifying the size, growth, and leading players in the otc pharmaceuticals market in Norway
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Norway
Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Norway otc pharmaceuticals market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Norway economy
Key Questions AnsweredWhat was the size of the Norway otc pharmaceuticals market by value in 2013?
What will be the size of the Norway otc pharmaceuticals market in 2018?
What factors are affecting the strength of competition in the Norway otc pharmaceuticals market?
How has the market performed over the last five years?